CRISPR Therapeutics AG - Common Stock (CRSP)

561 filings reported holding CRSP - CRISPR Therapeutics AG - Common Stock as of Q2 2024.
CRISPR Therapeutics AG - Common Stock (CRSP) has 439 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 59,510,276 shares of 90,438,636 outstanding shares and own 66% of the company stock.
Largest 10 shareholders include Capital International Investors (7,865,253 shares), ARK Investment Management LLC (7,778,536 shares), Sumitomo Mitsui Trust Holdings, Inc. (3,151,514 shares), Nikko Asset Management Americas, Inc. (3,151,514 shares), BlackRock Inc. (2,777,784 shares), T. Rowe Price Investment Management, Inc. (2,730,652 shares), STATE STREET CORP (2,393,684 shares), FMR LLC (2,353,091 shares), VANGUARD GROUP INC (1,748,513 shares), and NEA Management Company, LLC (1,587,854 shares).
This table shows the top 439 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.